AG
CMD

Advisor Group’s Cantel Medical Corporation CMD Stock Holding History

Advisor Group’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$207K Buy
2,930
+643
+28% +$46.6K ﹤0.01% 2368
2019
Q3 		$172K Buy
2,287
+231
+11% +$19.6K ﹤0.01% 2438
2019
Q2 		$166K Sell
2,056
-228
-10% -$16K ﹤0.01% 2466
2019
Q1 		$153K Sell
2,284
-518
-18% -$39.2K ﹤0.01% 2505
2018
Q4 		$209K Buy
2,802
+67
+2% +$5.53K ﹤0.01% 2062
2018
Q3 		$252K Buy
2,735
+897
+49% +$85.4K ﹤0.01% 1993
2018
Q2 		$181K Sell
1,838
-85
-4% -$9.51K ﹤0.01% 2054
2018
Q1 		$214K Sell
1,923
-594
-24% -$66.6K ﹤0.01% 1929
2017
Q4 		$259K Sell
2,517
-186
-7% -$18.5K ﹤0.01% 1792
2017
Q3 		$255K Sell
2,703
-479
-15% -$37.8K ﹤0.01% 1656
2017
Q2 		$249K Sell
3,182
-32
-1% -$2.4K ﹤0.01% 1626
2017
Q1 		$259K Sell
3,214
-492
-13% -$39.1K 0.01% 1473
2016
Q4 		$292K Sell
3,706
-590
-14% -$45.8K 0.01% 1320
2016
Q3 		$336K Buy
4,296
+342
+9% +$24.8K 0.01% 1205
2016
Q2 		$270K Buy
+3,954
New +$273K 0.01% 1253

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Advisor Group's CMD Position: Q4 2019 in Review

Advisor Group increased its Cantel Medical Corporation (CMD) stake by 28% in Q4 2019, buying an estimated $46.6K and bringing the position to 2,930 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #2368.

Advisor Group first reported a position in CMD in Q2 2016 and has held it in 15 quarters since. The position peaked at $336K in Q3 2016. 237 funds tracked by Wall St. Rank hold CMD as of Q4 2019.

  • Advisor Group held 2,930 shares of Cantel Medical Corporation worth $207K as of Q4 2019.
  • Advisor Group bought 643 Cantel Medical Corporation shares in Q4 2019, an estimated $46.6K.
  • Cantel Medical Corporation made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2368 holding.
  • Advisor Group first reported a position in Cantel Medical Corporation in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Cantel Medical Corporation position peaked at $336K in Q3 2016.
  • 237 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.